The FIGHT trial (Functional Impact of GLP-1 for HF Treatment) included 300 HFrEF patients with or without T2DM with a recent decompensation and were randomized to liraglutide or placebo for 6 months (86). Here, GLP1R is linked to hydrops fetalis.